Latest news with #PradhanMantriBhartiyaJanaushadhiPariyojana
India Gazette
18-05-2025
- Health
- India Gazette
From generic drugs to vaccines, Indian pharma industry is transforming lives worldwide
New Delhi [India], May 18 (ANI): India has transformed itself into a global health leader in terms of affordability, innovation, and inclusivity over the past decade. India's pharmaceutical industry is a global giant ranking third in volume and 14th in value. It's the largest supplier of generic medicines providing 20 per cent of the world's supply and a key player in affordable vaccines. In 2023-24, the sector's turnover hit Rs 4,17,345 crore growing steadily at over 10 per cent annually for the past five years. For the common people, this means more medicines at lower prices, better healthcare and jobs in factories and labs across the country. From small towns to big cities, India's pharma growth is creating opportunities and saving lives. The government claims that its schemes are the backbone of this success. The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) runs 15,479 Jan Aushadhi Kendras, offering generic medicines at prices up to 80 per cent lower than branded ones. A heart medicine that once cost Rs 500 might now cost Rs 100. The Production Linked Incentive (PLI) Scheme for Pharmaceuticals with Rs 15,000 crore, supports 55 projects to make high-end drugs like cancer and diabetes medicines right here in India. Another PLI scheme with Rs 6,940 crore focuses on raw materials like Penicillin G, reducing our need for imports. The PLI for Medical Devices backed by Rs 3,420 crore is boosting production of tools like MRI machines and heart implants. Then there's the Promotion of Bulk Drug Parks scheme with Rs 3,000 crore building mega hubs in Gujarat, Himachal Pradesh and Andhra Pradesh to make medicines cheaper and faster. The Strengthening of Pharmaceuticals Industry (SPI) Scheme with Rs 500 crore, funds research and upgrades labs, helping Indian companies compete globally. 'These efforts mean medicines are made in India, for India and for the world keeping costs low and quality high,' the government said in a statement. India's pharma sector supplies 55-60 per cent of UNICEF's vaccines, meeting 99 per cent of WHO's DPT (Diphtheria, Whooping cough and Tetanus) vaccine demand, 52 per cent for BCG (Bacillus Calmette-Guerin is a vaccine primarily used against TB), and 45 per cent for measles. From Africa to America, Indian vaccines save millions. At home, these schemes create jobs for young Indians, from factory workers to scientists. Foreign investors are pouring in with Rs 12,822 crore in 2023-24 alone, because they see India's potential. India welcomes 100 per cent foreign investment in medical devices and greenfield pharma projects, making India a hotspot for global companies. India's pharmaceutical sector is more than an industry; it's a lifeline. With schemes like PMBJP, PLI, and Bulk Drug Parks, the Modi government is ensuring no one is left behind when it comes to healthcare. From affordable medicines at Jan Aushadhi Kendras to vaccines reaching the world, India is building a healthier, self-reliant future. (ANI)
Time of India
12-05-2025
- Health
- Time of India
Medicine supply: HLL inks deal with Maldives govt
T'puram: HLL Lifecare signed a strategic partnership with the govt of Maldives for supply of essential medicines. State Trading Organization Plc (STO), a govt of Maldives enterprise responsible for the import and distribution of essential goods, signed the agreement with HLL under India's Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), a govt initiative aimed at providing affordable, high-quality medicines to the partnership ensures a continuous and affordable supply of essential medicines to every corner of the Maldives. Over the past year, the Maldives' health system faced challenges with frequent stock-outs of vital pharmaceuticals, disrupting patient care and placing significant strain on Aasandha, the national health insurance imports restored 99% of the availability of essential medicines by April, but short-term solutions alone cannot ensure sustainable access. This agreement with HLL turns emergency relief into a permanent supply solution. This history of collaboration gives STO confidence that HLL can meet its needs. TNN
India Gazette
10-05-2025
- Health
- India Gazette
India and Maldives strengthen healthcare partnership through supply of medicines by HLL under PMBJP Scheme
Thiruvananthapuram (Kerala) [India], May 10 (ANI): In a crucial association, India has committed its support to the Maldives by ensuring the supply of essential medicines through HLL Lifecare Limited - a Government of India enterprise under the Ministry of Health & Family Welfare - solidifying the growing healthcare collaboration between the two nations. According to a release, in line with this initiative, the State Trading Organization Plc (STO) - a Government of Maldives enterprise responsible for the import and distribution of essential goods - has signed a strategic agreement with HLL under India's Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), a government initiative aimed at providing affordable, high-quality medicines to the public. This partnership ensures a continuous and affordable supply of essential medicines to every corner of the Maldives. As per the release, over the past year, the Maldives' health system has faced challenges with frequent stock-outs of vital pharmaceuticals, disrupting patient care and placing significant strain on Aasandha, the national health insurance scheme. Emergency imports restored 99 percent of the availability of essential medicines by April, but short-term solutions alone cannot ensure sustainable access. This agreement with HLL turns emergency relief into a permanent supply solution. According to HLL has proven to be a dependable partner during past crises. During the COVID-19 pandemic, HLL supplied critical medical supplies to the Maldives, demonstrating its capacity to quickly and efficiently manage large-scale exports. This history of collaboration gives STO confidence that HLL can meet both current and future needs. By linking with HLL's extensive Janaushadhi network, which provides over 2,000 quality-assured generics and 300 surgical items, the Maldives taps into one of the world's most efficient pharmaceutical supply chains. (ANI)
Hans India
10-05-2025
- Health
- Hans India
India and Maldives strengthen healthcare partnership
Thiruvananthapuram: In a crucial association, India has committed its support to the Maldives by ensuring the supply of essential medicines through HLL Lifecare Limited - a Government of India enterprise under the Ministry of Health & Family Welfare, solidifying the growing healthcare collaboration between the two nations. In line with this initiative, the State Trading Organization Plc (STO) - a Government of Maldives enterprise responsible for the import and distribution of essential goods - has signed a strategic agreement with HLL under India's Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP), a government initiative aimed at providing affordable, high-quality medicines to the public. This partnership ensures a continuous and affordable supply of essential medicines to every corner of the Maldives. Over the past year, the Maldives' health system has faced challenges with frequent stock-outs of vital pharmaceuticals, disrupting patient care and placing significant strain on Aasandha, the national health insurance scheme. Emergency imports restored 99 per cent of the availability of essential medicines by April, but short-term solutions alone cannot ensure sustainable access. This agreement with HLL turns emergency relief into a permanent supply solution. HLL has proven to be a dependable partner during past crises. During the COVID-19 pandemic, HLL supplied critical medical supplies to the Maldives, demonstrating its capacity to quickly and efficiently manage large-scale exports. This history of collaboration gives STO confidence that HLL can meet both current and future needs. By linking with HLL's extensive Janaushadhi network, which provides over 2,000 quality-assured generics and 300 surgical items, the Maldives taps into one of the world's most efficient pharmaceutical supply chains. Established in 1966 and with its headquarters in the state capital city, HLL has come a long way as part of the implementation of the Family Planning Programme under the Ministry of Health & Family welfare and a contraceptive making company, it is now a total healthcare company and in its growth trajectory, it has won numerous accolades not only from the government but at international level too. Currently, there are close to 10,000 employees in various categories at HLL, which include 3,900 direct employees and the rest comprises contract third-party and laboratory staff. The HLL have, by now, supplied medical devices to various medical institutions in 29 states and seven Union Territories. It ended the previous fiscal with a turnover of Rs 5,081 crore and had a profit of Rs 112 crore.
Hans India
29-04-2025
- Health
- Hans India
Gujarat: Jan Aushadhi Kendra becomes a boon for Jamnagar people, offering medicines at low price
Jamnagar (Gujarat): Lakhs of families across India are reaping significant financial benefits through the Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP). The Kendras under this scheme provide affordable yet high-quality medicines, bringing substantial change to the lives of the poor and middle-class populations. In Gujarat's Jamnagar, the Pradhan Mantri Jan Aushadhi Kendra located on ST Road has become especially beneficial for local residents. People from middle and low-income backgrounds have expressed deep gratitude to Prime Minister Narendra Modi and the central government for the positive impact of this initiative. IANS spoke to a few beneficiaries of this scheme, who shared their experiences. Nilesh, one of the beneficiaries, shared his experience: 'I have been purchasing medicines from the Jan Aushadhi Kendra for a long time. Earlier, I used to buy them from private medical stores, where they cost around Rs 700 to 800. The same medicines now cost only Rs 200 to 250 here, saving me a lot of money. I would encourage everyone to buy their medicines from Jan Aushadhi Kendras.' Another beneficiary, Dev, said, 'I buy medicines for my parents from the Jan Aushadhi Kendra. Previously, we had to spend much more at private pharmacies, but now we are able to save a considerable amount.' Jayesh Kawaiya, director of the Jan Aushadhi Kendra in Jamnagar, said he came to know about the scheme in 2017, when he was still working for a private company. 'I left my job and decided to open a Jan Aushadhi Kendra. Initially, we had very few customers, but as awareness grew, more people started visiting, and the centre began operating successfully. The scheme has not only helped me as an entrepreneur, but it has also benefited customers through access to affordable medicines.' He added, 'I sincerely thank Prime Minister Modi for this initiative, which has become a blessing for the poor.' The PMBJP was launched in November 2008 by the Department of Pharmaceuticals under the Ministry of Chemicals and Fertilisers, in collaboration with Central Pharma Public Sector Undertakings. The aim is to make quality generic medicines available at affordable prices for all. Under this scheme, dedicated outlets -- Pradhan Mantri Bhartiya Janaushadhi Kendras -- are established across the country. Every year, March 7 is celebrated as Jan Aushadhi Diwas to raise awareness and promote the use of generic medicines. Recently, a week-long series of events was organised from March 1 to 7 to support and aware the people about the initiative.
